No abstract available
MeSH terms
-
2-Pyridinylmethylsulfinylbenzimidazoles
-
Aryl Hydrocarbon Hydroxylases / genetics*
-
Benzimidazoles / therapeutic use
-
Cytochrome P-450 CYP2C19
-
Drug Interactions
-
Famotidine / therapeutic use
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Kidney Transplantation / physiology*
-
Lansoprazole
-
Male
-
Middle Aged
-
Mixed Function Oxygenases / genetics*
-
Omeprazole / analogs & derivatives
-
Omeprazole / therapeutic use
-
Proton Pump Inhibitors*
-
Rabeprazole
-
Tacrolimus / therapeutic use*
Substances
-
2-Pyridinylmethylsulfinylbenzimidazoles
-
Benzimidazoles
-
Immunosuppressive Agents
-
Proton Pump Inhibitors
-
Lansoprazole
-
Rabeprazole
-
Famotidine
-
Mixed Function Oxygenases
-
Aryl Hydrocarbon Hydroxylases
-
CYP2C19 protein, human
-
Cytochrome P-450 CYP2C19
-
Omeprazole
-
Tacrolimus